Program Evaluation to Aid Choice of Aripiprazole or Risperidone for Hospitalized Adolescents with Cannabis Use Disorder and Psychosis
Journal of Child and Adolescent Psychopharmacology · 2023
DOI: 10.1089/cap.2023.0053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, 2023. Verfasst von Christian Thurstone und 4 weiteren Autor:innen. Beteiligte Einrichtung: Denver Health and Hospital Authority, Denver, Colorado, USA. Hauptthemen laut MEDLINE: Antipsychotic Agents, Adolescent, Hospitalized, Marijuana Abuse, Psychotic Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Denver Health and Hospital Authority, Denver, Colorado, USA.
- University of Colorado, Department of Psychiatry, Aurora, Colorado, USA.
ORCID-Profile: Christian Thurstone
Zitieren
APA
Thurstone, C., Loh, R., Foreman, K., Thurstone, C. A., & Wolf, C. (2023). Program Evaluation to Aid Choice of Aripiprazole or Risperidone for Hospitalized Adolescents with Cannabis Use Disorder and Psychosis. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2023.0053
Vancouver
Thurstone C, Loh R, Foreman K, Thurstone CA, Wolf C. Program Evaluation to Aid Choice of Aripiprazole or Risperidone for Hospitalized Adolescents with Cannabis Use Disorder and Psychosis. Journal of Child and Adolescent Psychopharmacology. 2023. doi:10.1089/cap.2023.0053
BibTeX
@article{Thurstone2023,
author = {Thurstone, Christian and Loh, Ryan and Foreman, Kristina and Thurstone, Christian A and Wolf, Chelsea},
title = {Program Evaluation to Aid Choice of Aripiprazole or Risperidone for Hospitalized Adolescents with Cannabis Use Disorder and Psychosis},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2023},
doi = {10.1089/cap.2023.0053}
}
EUVIMED